Testing a flu vaccine with adjuvant in adults
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new flu vaccine with an ingredient to boost your immune response. It's for adults who haven't had the flu or a flu shot in the past 6 months and are generally healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have not gotten a flu shot in the last 6 months.
- You have not had the flu (confirmed by a test) in the last 6 months.
- You are not allergic to eggs or any vaccine ingredients.
- You do not have a weakened immune system or a serious health condition.
- You are not pregnant, breastfeeding, or planning to get pregnant in the next year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This trial tests a flu vaccine (split virus type) for adults aged 60+ to see how well it works and how safe it is. It might help protect older adults from the flu.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.